United States · FDA National Drug Code directory
BENLYSTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49401-102_eb71b011-8919-478c-bed7-b94709fcd596
- Product NDC
- 49401-102
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- belimumab
- Labeler
- GlaxoSmithKline LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20110310
- Source listing expiry
- 20271231
Source-listed ingredients
- BELIMUMAB — 400 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (49401-102-01) / 5 mL in 1 VIAL · 49401-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →